Your browser doesn't support javascript.
loading
AN0025, a novel antagonist of PGE2-receptor E-type 4 (EP4), in combination with total neoadjuvant treatment of advanced rectal cancer.
Wyrwicz, Lucjan; Saunders, Mark; Hall, Marcia; Ng, John; Hong, Theodore; Xu, Sherry; Lucas, Justin; Lu, Xuyang; Lautermilch, Nathan; Formenti, Silvia; Glynne-Jones, Robert.
Afiliação
  • Wyrwicz L; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland. Electronic address: lucjan.wyrwicz@pib-nio.pl.
  • Saunders M; Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Hall M; Medical Oncology, Mount Vernon Cancer Centre, Northwood, United Kingdom.
  • Ng J; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, United States.
  • Hong T; Massachusetts General Hospital, Harvard Medical School, Hatfield, United Kingdom.
  • Xu S; Adlai Nortye USA, North Brunswick, NJ, United States.
  • Lucas J; Adlai Nortye USA, North Brunswick, NJ, United States.
  • Lu X; Adlai Nortye USA, North Brunswick, NJ, United States.
  • Lautermilch N; Adlai Nortye USA, North Brunswick, NJ, United States.
  • Formenti S; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, United States.
  • Glynne-Jones R; Medical Oncology, Mount Vernon Cancer Centre, Northwood, United Kingdom.
Radiother Oncol ; 185: 109669, 2023 08.
Article em En | MEDLINE | ID: mdl-37054987

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Dinoprostona Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Dinoprostona Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article